Organon (OGN) Earnings (2020 - 2026)
Organon (OGN) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM Organon (OGN) earnings is $246M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Organon (OGN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -67.20% |
| 3 Years TTM | -30.91% |
| 5 Years TTM | -33.25% |
| All Time TTM | -33.25% |
Annual Earnings change of Organon (OGN)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $146M | -21.93% |
| 2025 | $187M | -78.36% |
| 2024 | $864M | -15.54% |
| 2023 | $1.02B | +11.56% |
| 2022 | $917M | -32.12% |
| 2021 | $1.35B | -37.45% |
| 2020 | $2.16B | -32.88% |
| 2019 | $3.22B | N/A |
Comparison Organon (OGN) five years earnings CAGR with competitors
Organon (OGN) five years earnings CAGR is -33.25%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 98.24% | -395.49% |
| LLY | Lilly(Eli) & Company | 32.92% | -199.01% |
| NVO | Novo Nordisk | 23.10% | -169.49% |
| AZN | Astrazeneca plc | 21.17% | -163.68% |
| NVS | Novartis AG | 11.21% | -133.73% |
| JNJ | Johnson & Johnson | 6.84% | -120.57% |
| MRK | Merck & Co Inc | 4.92% | -114.80% |
| GSK | GSK Plc | 2.84% | -108.55% |
| AMGN | AMGEN Inc | 1.94% | -105.84% |